Stomach Cancer Awareness Month

Gastric cancer

, commonly referred to as stomach cancer, is a condition in which the stomach’s lining develops cancerous cells. The mucosal layer, the muscularis layer, and the serosal layer are the three layers of tissue that make up the stomach wall. As it develops, stomach cancer spreads to the outer layers of the cells lining the mucosal layer where it first appears.

About 90% of stomach tumours are adenocarcinomas, which develop in glands that secrete mucus. Lymphoma, an immune system-related malignancy, affects about 5% of them. Furthermore, some stomach tumours are of the carcinoid type, a neuroendocrine malignancy that grows slowly.

Treatment for stomach stromal tumours, which originate in the connective tissue that supports the stomach, differs from that for gastric cancer. An important function is served by November’s Stomach Cancer Awareness Month. The purpose of the month is to inform people about gastric and stomach cancer and to raise awareness of the disease. In order to recognise cancer early and prevent it before it poses a threat to one’s life, awareness is important. Do you frequently experience digestive problems? Even if it might not be anything, getting checked out is never a bad idea. So, make a positive move and schedule a medical visit for yourself in November. It is ultimately preferable to be safe than sorry.

No Stomach For Cancer (N.S.F.C.) created Stomach Cancer Awareness Month in 2010. The No Stomach For Cancer (N.S.F.C.) claims that if stomach cancer symptoms are discovered at an early stage, they can be controlled. Constant heartburn, bloating, nausea, and persistent indigestion are among the early signs of stomach cancer. One may have stomach pain, blood in the stool, abrupt weight loss, vomiting, and difficulty swallowing as the patient’s health deteriorates. Stomach cancer patients had a five-year survival rate of 70%.

Gastric cancer is the fifth most common cancer among males and the seventh most common cancer among females in India. The aggressiveness of the disease and the need for improvement in therapeutic options is discerned by the fact that gastric cancer is the second most common cause of cancer death globally. The high rate of local and distant recurrence, even in patients with entirely curable gastric cancer, suggests that the disease’s systemic spread of cancer began very early. This emphasises the importance of multimodality treatment, which includes surgery, radiation, and chemotherapy.

The incidence of gastric cancer in India is low compared to developed countries, though there are certain geographical areas (Southern part and north-eastern states of the country) where the incidence is comparable to high-incidence areas of the world. Despite the high number of patients receiving treatment for stomach cancer, the number of publications examining risk factors and patient outcomes is insufficient.